| Clarivate Analytics plc. (1/17/20). "Press Release: Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry". London & Philadelphia, PA. |
2020-01-17 |
| Charles River Laboratories International, Inc.. (1/16/20). "Press Release: Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment". Wilmington, MA & Edinburgh. |
2020-01-16 |
| BioNTech SE. (1/16/20). "Press Release: BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies". Mainz & Cambridge, MA. |
2020-01-16 |
| Jeito Capital. (1/15/20). "Press Release: Rafaèle Tordjman Launches Jeito Capital, a New Private Equity Company Dedicated to Biotech-biopharmaceuticals, and Announces the Closing of Jeito I at €200 Million". Paris. |
2020-01-15 |
| Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. |
2020-01-14 |
| Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. |
2020-01-14 |
| Roche. (1/13/20). "Press Release: Roche and Illumina Partner to Broaden Patient Access to Genomic Testing". Basel. |
2020-01-13 |
| KCR S.A.. (1/13/20). "Press Release: KCR Announces New Chief Commercial Officer. Bryan Katz Joins KCR’s Growing Executive Team to Take Over as Head of Commercial Strategy and Global Partnerships". Boston, MA. |
2020-01-13 |
| MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE. |
2020-01-13 |
| Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. |
2020-01-13 |
| Cellectis S.A.. (1/12/20). "Press Release: Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement". San Carlos, CA & New York, NY. |
2020-01-12 |
| EQRx, Inc.. (1/12/20). "Press Release: EQRx Launches to Create Innovative Medicines at Dramatically Lower Prices for People, Healthcare Systems and Society". Cambridge, MA. |
2020-01-12 |
| Eli Lilly and Company. (1/10/20). "Press Release: Lilly Announces Agreement to Acquire Dermira". Indianapolis, IN & Menlo Park, CA. |
2020-01-10 |
| Tyra Biosciences, Inc.. (1/10/20). "Press Release: Tyra Biosciences Raises $50m to Develop Therapies Targeting Acquired Resistance in Oncology". Carlsbad, CA. |
2020-01-10 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Signs a Strategic Agreement with 23andMe to License Rights of a Bispecific Monoclonal Antibody that Blocks All Three Isoforms of IL-36 Cytokine". Barcelona & Sunnyvale, CA. |
2020-01-09 |
| Nurix Therapeutics, Inc.. (1/9/20). "Press Release: Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies". San Francisco, CA. |
2020-01-09 |
| Element Biosciences, Inc.. (1/9/20). "Press Release: Element Biosciences Raises $80M in Series B Financing to Accelerate Development of a New DNA Sequencing Platform". San Diego, CA. |
2020-01-09 |
| Evotec SE. (1/9/20). "Press Release: Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome". Hamburg & Berlin. |
2020-01-09 |
| Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva. |
2020-01-09 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Enters into an Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical Dermatology". Barcelona. |
2020-01-09 |
| Grey Wolf Therapeutics Ltd.. (1/9/20). "Press Release: Grey Wolf Completes £2.5 Million Series A2 Financing for Development of Therapies Targeting ERAP2". Oxford. |
2020-01-09 |
| Emergex Vaccines Holding Ltd.. (1/9/20). "Press Release: Emergex Raises more than US$11 Million in a Series A Round to Progress its Pipeline of Set-point Vaccines for Infectious Diseases". Abingdon. |
2020-01-09 |
| NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. |
2020-01-08 |
| GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. |
2020-01-08 |
| BC Platforms. (1/8/20). "Press Release: BC Platforms Partners with Dante Labs to Build Europe's Largest Next Generation Sequencing Laboratory for Private and Public Customers". Zürich & Boston, MA. |
2020-01-08 |
| Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. |
2020-01-08 |
| VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. |
2020-01-07 |
| Novome Biotechnologies, Inc.. (1/7/20). "Press Release: Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer". South San Francisco, CA. |
2020-01-07 |
| Evotec SE. (1/7/20). "Press Release: Evotec and Bristol-Myers Squibb Expand iPSC Collaboration". Hamburg. |
2020-01-07 |
| Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. |
2020-01-07 |
| ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. |
2020-01-07 |
| Bayer AG. (1/7/20). "Press Release: Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise. Companies to Continue Crop Protection Development Programs". Monheim & San Francisco, CA. |
2020-01-07 |
| Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. |
2020-01-06 |
| MorphoSys AG. (12/30/19). "Press Release: MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA". Planegg. |
2019-12-30 |
| Elpiscience Biopharma. (12/28/19). "Press Release: Elpiscience Completes Series B Financing of USD $100 Million". Shanghai. |
2019-12-28 |
| Astellas Pharma Inc.. (12/27/19). "Pressemitteilung: Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.". Tokyo & South San Francisco, CA. |
2019-12-27 |
| Codexis, Inc.. (12/23/19). "Press Release: Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing". Redwood City, CA. |
2019-12-23 |
| Savara Inc.. (12/20/19). "Press Release: Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million". Austin, TX. |
2019-12-20 |
| Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Announces $20 Million Registered Direct Offering". Dublin & King of Prussia, PA. |
2019-12-20 |
| Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Resubmits New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. |
2019-12-20 |
| Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt. |
2019-12-19 |
| Kinnate Biopharma, Inc.. (12/19/19). "Press Release: Kinnate Biopharma Closes $74.5M Series B Financing". San Diego, CA. |
2019-12-19 |
| Flagship Pioneering. (12/19/19). "Press Release: Flagship Unveils Newest Pioneering Platform: Ring Therapeutics". Cambridge, MA. |
2019-12-19 |
| Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. |
2019-12-19 |
| Forma Therapeutics, Inc.. (12/19/19). "Press Release: Forma Therapeutics Announces Closing of $100 Million Series D Financing". Watertown, MA. |
2019-12-19 |
| BC Platforms. (12/18/19). "Press Release: BC Platforms Closes $15 Million Series C Financing and Signs Partnership with Iqvia to Extend Data Analytics in Genomics". Zürich & Boston, MA. |
2019-12-18 |
| KCR S.A.. (12/18/19). "Press Release: KCR Adopts Veeva Vault Clinical Suite". Boston, MA. |
2019-12-18 |
| Ferring Pharmaceuticals S.A.. (12/18/19). "Press Release: FerGene Appoints David Meek Chief Executive Officer". Cambridge, MA. |
2019-12-18 |
| Deerfield Management Company L.P.. (12/18/19). "Press Release: Duke University and Deerfield Management Announce Four Points Innovation". Durham, NC & New York, NY. |
2019-12-18 |
| Pathios Therapeutics Ltd.. (12/18/19). "Press Release: Pathios Closes US$8.8m Series A and Appoints Stuart Hughes as CEO". Oxford. |
2019-12-18 |
| Genomill Health. (12/18/19). "Press Release: Genomill Health Closes Investment Round to Expand Beta-testing with Liquid Biopsy Players". Turku. |
2019-12-18 |
| Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris. |
2019-12-18 |
| Epirium Bio, Inc.. (12/18/19). "Press Release: Epirium Raises $85 Million in Series A Financing to Advance Unique Scientific Platform Focused on Restoration of Tissue Bioenergetics and Function". San Francisco, CA. |
2019-12-18 |
| Evotec SE. (12/18/19). "Press Release: Evotec Expands Service Agreement with Sanofi to Create a Centralised Global Sample Management Hub in Toulouse". Hamburg. |
2019-12-18 |
| Seer, Inc.. (12/17/19). "Press Release: Seer Announces $55 Million in Series D Equity Financing. Bringing in New Investors aMoon Fund and T. Rowe Price Funds". Redwood City, CA. |
2019-12-17 |
| Roche. (12/17/19). "Press Release: Roche Concludes Acquisition of Spark Therapeutics, Inc. to Strengthen Presence in GeneTherapy". Basel. |
2019-12-17 |
| Federal Trade Commission. (12/17/19). "Press Release: FTC Challenges Illumina’s Proposed Acquisition of PacBio". |
2019-12-17 |
| ArcherDX, Inc.. (12/17/19). "Press Release: ArcherDX Announces Close of $55 Million Series C Financing". Boulder, CO. |
2019-12-17 |
| Sphingotec GmbH. (12/16/19). "Press Release: Sphingotec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. |
2019-12-16 |
| Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe |
2019-12-16 |
| GlaxoSmithKline plc. (12/16/19). "Press Release: Pivotal DREAMM-2 Study Demonstrated a Clinically Meaningful Overall Response Rate with Belantamab Mafodotin (GSK2857916) for Patients with relapsed/refractory Multiple Myeloma". London. |
2019-12-16 |
| Federal Trade Commission. (12/16/19). "Press Release: Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.". |
2019-12-16 |
| Flagship Pioneering. (12/16/19). "Press Release: Flagship Pioneering Strengthens Leadership with Appointment of Paul Biondi as Executive Partner". Cambridge, MA. |
2019-12-16 |
| Genmab A/S. (12/13/19). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma". Copenhagen. |
2019-12-13 |
| Boehringer Ingelheim. (12/13/19). "Press Release: Boehringer Ingelheim and Lilly Provide Update on Empagliflozin Phase III Exercise Ability Studies in Chronic Heart Failure". Ingelheim & Indianapolis, IN. |
2019-12-13 |
| Aelis Farma. (12/13/19). "Press Release: Aelis Farma Raises €11 Million to Accelerate the Clinical Development of a Paradigm-Shifting New Class of Drugs for Treating Cannabis Addiction and Cognitive Disorders". Bordeaux. |
2019-12-13 |
| iTeos Therapeutics S.A.. (12/12/19). "Press Release: iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with Keytruda". Gosselies & Cambridge, MA. |
2019-12-12 |
| Charles River Laboratories International, Inc.. (12/10/19). "Press Release: Charles River Announces Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies". Wilmington, MA. |
2019-12-10 |
| Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich). |
2019-12-10 |
| Stilla Technologies S.A.S.. (12/10/19). "Press Release: Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution". Paris. |
2019-12-10 |
| ImmunOs Therapeutics AG. (12/10/19). "Press Release: ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer into Human Trials". Schlieren. |
2019-12-10 |
| Inscripta, Inc.. (12/10/19). "Press Release: Inscripta Raises $125m in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform". Boulder, CO. |
2019-12-10 |
| Bioncotech Therapeutics S.L.. (12/10/19). "Press Release: Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD. Phase II Trial with Combination of BO-112 and Pembrolizumab". Madrid. |
2019-12-10 |
| Markes International Ltd.. (12/10/19). "Press Release: Markes Becomes Licensed World Commercial Supplier of Thin-Film Solid-Phase Microextraction (TF-SPME)". |
2019-12-10 |
| Algiax Pharmaceuticals. (12/9/19). "Press Release: Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors". Düsseldorf. |
2019-12-09 |
| Sanofi S.A.. (12/9/19). "Press Release: Sanofi to Acquire Synthorx to Bolster Its Immuno-oncology Pipeline for $2.5 Billion". Paris & San Diego, CA. |
2019-12-09 |
| ObsEva S.A.. (12/9/19). "Press Release: ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix". Geneva & Boston, MA. |
2019-12-09 |
| Epidarex Capital. (12/9/19). "Press Release: Epidarex Exeed Founded by Epidarex Capital to Advance Early Stage, Highly Innovative Life Science Assets". Edinburgh. |
2019-12-09 |
| Bruker Corporation. (12/9/19). "Press Release: Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging". Washington, DC. |
2019-12-09 |
| Merck & Co., Inc.. (12/9/19). "Press Release: Merck to Acquire ArQule, Advancing Leadership in Oncology". Kenilworth, NJ & Burlington, MA. |
2019-12-09 |
| Jasper Therapeutics, Inc.. (12/6/19). "Press Release: Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants". Palo A |
2019-12-06 |
| Sartorius AG. (12/5/19). "Press Release: Sartorius Supervisory Board Extends Appointment of Group CEO Joachim Kreuzburg". Göttingen. |
2019-12-05 |
| Sartorius AG. (12/5/19). "Press Release: Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries". Göttingen. |
2019-12-05 |
| Limelight Bio. (12/5/19). "Press Release: Limelight Bio Emerges with $75 Million to Develop Next Generation Gene Therapies to Overcome Limitations of Current Treatments". Philadeliphia, PA & Cambridge, MA. |
2019-12-05 |
| Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC. |
2019-12-05 |
| ImCheck Therapeutics S.A.S.. (12/4/19). "Press Release: ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases". Marseille. |
2019-12-04 |
| Civetta Therapeutics, LLC. (12/4/19). "Press Release: Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins
Civetta Therapeutics is a Deerfield Founded and Funded Comp |
2019-12-04 |
| Ligand Pharmaceuticals Inc.. (12/2/19). "Press Release: Ligand Enters into Worldwide OmniAb Platform License Agreement with Sanofi". San Diego, CA. |
2019-12-02 |
| CureVac AG. (12/2/19). "Press Release: CureVac Granted Manufacturing Authorization for Its Third GMP Production Suite". Tübingen & Boston, MA. |
2019-12-02 |
| Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. |
2019-12-02 |
| Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York. |
2019-12-02 |
| Audentes Therapeutics, Inc.. (12/2/19). "Press Release: Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics". Tokyo & San Francisco, CA. |
2019-12-02 |
| Puma Biotechnology, Inc.. (12/2/19). "Press Release: Puma Biotechnology Amends License Agreement with Pierre Fabre to Include Additional Countries". Berlin. |
2019-12-02 |
| Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier. |
2019-12-02 |
| Diabeloop S.A.. (12/2/19). "Press Release: Diabeloop Completes Record-breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions". Grenoble. |
2019-12-02 |
| MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. |
2019-11-28 |
| Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. |
2019-11-27 |
| Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. |
2019-11-26 |
| Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. |
2019-11-26 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. |
2019-11-26 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
Date![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
